DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,785,552 | -30.0% | 474,336 | +0.1% | 0.01% | -27.3% |
Q2 2023 | $13,985,055 | +28.1% | 473,909 | +0.0% | 0.01% | +22.2% |
Q1 2023 | $10,915,960 | -16.9% | 473,783 | +0.3% | 0.01% | -18.2% |
Q4 2022 | $13,134,329 | -9.4% | 472,288 | -0.0% | 0.01% | -15.4% |
Q3 2022 | $14,497,000 | +5.0% | 472,374 | +0.7% | 0.01% | +18.2% |
Q2 2022 | $13,811,000 | -20.0% | 469,281 | -12.5% | 0.01% | -8.3% |
Q1 2022 | $17,258,000 | -27.8% | 536,471 | +0.0% | 0.01% | -20.0% |
Q4 2021 | $23,918,000 | +35.9% | 536,282 | +53.7% | 0.02% | +25.0% |
Q3 2021 | $17,606,000 | -23.4% | 348,987 | +19.2% | 0.01% | -25.0% |
Q2 2021 | $22,971,000 | +38.1% | 292,847 | +0.6% | 0.02% | +33.3% |
Q1 2021 | $16,630,000 | -38.9% | 291,242 | -10.4% | 0.01% | -42.9% |
Q4 2020 | $27,213,000 | +82.4% | 324,888 | -22.0% | 0.02% | +61.5% |
Q3 2020 | $14,922,000 | +48.2% | 416,476 | +0.0% | 0.01% | +30.0% |
Q2 2020 | $10,067,000 | +38.2% | 416,346 | +0.1% | 0.01% | +11.1% |
Q1 2020 | $7,286,000 | -2.1% | 416,121 | -2.6% | 0.01% | +28.6% |
Q4 2019 | $7,439,000 | -0.2% | 427,047 | -12.3% | 0.01% | 0.0% |
Q3 2019 | $7,457,000 | -26.2% | 486,734 | 0.0% | 0.01% | -30.0% |
Q2 2019 | $10,105,000 | +71.8% | 486,734 | +92.2% | 0.01% | +66.7% |
Q1 2019 | $5,881,000 | – | 253,294 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |